TScan Therapeutics (TCRX) Capital Expenditures (2020 - 2026)
TScan Therapeutics (TCRX) recorded Capital Expenditures of $41,000 in Q3 2026, down 97.1% from $1.43 million a year earlier and down 91.7% from the prior quarter.
TScan Therapeutics (TCRX) Capital Expenditures (2020 - 2026) Analysis & Trends
On a TTM basis, TScan Therapeutics' Capital Expenditures came in at $775,000 as of Sep 30, 2026, down 84.9% year-over-year; for FY2025, it was $4.41 million, up 15.2% from FY2024.
- Annual Capital Expenditures has a five-year compound annual growth rate of 0.8% (FY2020 to FY2025).
- Across earlier years, Capital Expenditures came in at $3.83 million in FY2024 (+21.6%), $3.15 million in FY2023 (-25.5%), $4.23 million in FY2022 (-57.5%) and $9.94 million in FY2021 (+134.6%).
- The Q3 2026 figure is the lowest quarterly Capital Expenditures in data going back to Q3 2020.
- On a year-over-year basis, Capital Expenditures has declined for four consecutive quarters, with an average decline of 9.5% over the last eight quarters.
- Peak year-over-year performance for Capital Expenditures in the last five years was growth of 234.7% in Q3 2023, against a decline of 97.1% in Q3 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $493,000 (Q2 2026), $70,000 (Q1 2026) and $171,000 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | PetVivo Holdings | 3,096.39 Bn | 3,096.39 Bn | 196,075.00 | -39,045.00 |
| 2 | Eli Lilly | 1,202.70 Bn | 1,176.32 Bn | 20.46 Bn | 3.18 Bn |
| 3 | Johnson & Johnson | 649.77 Bn | 569.63 Bn | 17.30 Bn | 1.36 Bn |
| 4 | AbbVie | 507.00 Bn | 475.00 Bn | 13.12 Bn | 301.00 Mn |
| 5 | Merck | 329.70 Bn | 292.64 Bn | 13.19 Bn | 1.04 Bn |
| 6 | Novartis Ag | 291.91 Bn | 265.14 Bn | - | - |
| 7 | Amgen | 236.26 Bn | 187.91 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 207.15 Bn | 182.26 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Gsk | 193.54 Bn | 176.38 Bn | - | - |
| 10 | TScan Therapeutics | 18.87 Mn | -434.83 Mn | - | 41,000.00 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 41,000.00 |
| Jun 30, 2026 | 493,000.00 |
| Mar 31, 2026 | 70,000.00 |
| Dec 31, 2025 | 171,000.00 |
| Sep 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | 1.28 Mn |
| Mar 31, 2025 | 1.53 Mn |
| Dec 31, 2024 | 888,000.00 |
| Sep 30, 2024 | 1.37 Mn |
| Jun 30, 2024 | 862,000.00 |
| Mar 31, 2024 | 705,000.00 |
| Dec 31, 2023 | 469,000.00 |
| Sep 30, 2023 | 1.42 Mn |
| Jun 30, 2023 | 420,000.00 |
| Mar 31, 2023 | 838,000.00 |
| Dec 31, 2022 | 1.38 Mn |
| Sep 30, 2022 | 424,000.00 |
| Jun 30, 2022 | 1.89 Mn |
| Mar 31, 2022 | 531,000.00 |
| Dec 31, 2021 | 2.21 Mn |
TScan Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TCRX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "TCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();